Reshape Lifesciences Stock (NASDAQ: RSLS) stock price, news, charts, stock research, profile.
Open | $5.90 |
Close | $7.99 |
Volume / Avg. | 7.75M / 23.28K |
Day Range | $5.03 - $12.13 |
52 Wk Range | 6.38 - 39.38 |
Market Cap | $225.11M |
P/E Ratio | 0.27 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 2.18% |
Days to Cover | 1.46 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Reshape Lifesciences (NASDAQ:RSLS) through any online brokerage.
Other companies in Reshape Lifesciences’s space includes: NeuroPace (NASDAQ:NPCE), Sight Sciences (NASDAQ:SGHT), Semler Scientific (NASDAQ:SMLR), AngioDynamics (NASDAQ:ANGO) and Fractyl Health (NASDAQ:GUTS).
Reshape Lifesciences has a consensus price target of $4.65.
The stock price for Reshape Lifesciences (NASDAQ: RSLS) is $7.66 last updated September 23, 2024 at 6:20 PM EDT.
There are no upcoming dividends for Reshape Lifesciences.
Reshape Lifesciences’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Reshape Lifesciences.
Reshape Lifesciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.